Literature DB >> 8887493

A murine RNA polymerase I promoter inserted into the herpes simplex virus type 1 genome is functional during lytic, but not latent, infection.

R H Lachmann1, C Brown, S Efstathiou.   

Abstract

The development of herpes simplex virus as a vector for neuronal gene delivery is dependent upon the identification and characterization of promoter elements capable of driving long-term expression during latency. The majority of RNA polymerase II (pol II) promoters studied are active during acute infection but silenced during latency. In order to investigate the potential of a murine RNA polymerase I (pol I) promoter to drive reporter gene expression during lytic and latent infection, we describe the construction and characterization of two recombinant viruses; SC16 LAT neo and SC16 US5 neo. These viruses contain a pol I-encephalomyocarditis virus internal ribosome entry site (EMCV IRES)-neomycin phosphotransferase gene (neoR) cassette inserted into the non-essential major latency associated transcript (LAT) and US5 regions respectively. Pol I promoter activity could be detected in the rodent BHK cell line, but not the primate derived Vero cell line-- consistent with the known species specificity of such promoters. This activity was specific to a virus containing an active pol I promoter. However, in situ hybridization analyses of latently infected cervical dorsal root ganglia failed to detect pol I mediated transcription of the reporter gene indicating that the murine pol I promoter is silenced following the establishment of latency. Insertion of the pol I-EMCV IRES-neoR cassette into the major LAT locus resulted in the production of a hybrid LAT transcript during latency which was translocated to the cytoplasm of latently infected neurones.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887493     DOI: 10.1099/0022-1317-77-10-2575

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system.

Authors:  J A Palmer; R H Branston; C E Lilley; M J Robinson; F Groutsi; J Smith; D S Latchman; R S Coffin
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 2.  Herpes simplex virus-based vectors.

Authors:  Robin Lachmann
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

3.  Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: acute phase replication and reactivation in mice.

Authors:  John W Balliet; Anna S Kushnir; Priscilla A Schaffer
Journal:  Virology       Date:  2007-01-17       Impact factor: 3.616

4.  Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.

Authors:  R H Lachmann; S Efstathiou
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  A novel Cre recombinase imaging system for tracking lymphotropic virus infection in vivo.

Authors:  Bernadette M Dutia; Stuart J Reid; Derek D Drummond; Yvonne Ligertwood; Ian Bennet; Willard Rietberg; Ondine Silvia; Michael A Jarvis; Anthony A Nash
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

6.  A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones.

Authors:  João T Proença; Heather M Coleman; Viv Connor; Douglas J Winton; Stacey Efstathiou
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

7.  Establishment of HSV1 latency in immunodeficient mice facilitates efficient in vivo reactivation.

Authors:  Chandran Ramakrishna; Adrianna Ferraioli; Aleth Calle; Thanh K Nguyen; Harry Openshaw; Patric S Lundberg; Patrick Lomonte; Edouard M Cantin
Journal:  PLoS Pathog       Date:  2015-03-11       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.